Ind-Swift Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Ind-Swift Lab.	Venus Remedies	Sakar Healthcare
Operational Metrics
Pharmaceuticals
Total reactor capacity	700.0 kL	n/a	n/a
DMF Filingsby API	474.0 .	n/a	n/a
R&D as a % of Total Sales	2.9 %	n/a	n/a
Financials
5 yr Average ROE	14.7 %	8.87 %	8.14 %
5yr average Equity Multiplier	2.17	1.32	1.76
5yr Average Asset Turnover Ratio	0.66	0.96	0.45
5yr Avg Net Profit Margin	16.17 %	6.91 %	10.03 %
Price to Book	0.92	2.09	3.91
P/E	4.82	16.28	41.58
5yr Avg Cash Conversion Cycle	15.71 Days	46.96 Days	18.72 Days
Inventory Days	103.91 Days	75.64 Days	51.79 Days
Days Receivable	105.66 Days	54.28 Days	53.06 Days
Days Payable	107.02 Days	58.86 Days	115.64 Days
5yr Average Interest Coverage Ratio	21.19	396.11	4.85
5yr Avg ROCE	12.09 %	8.42 %	8.92 %
5yr Avg Operating Profit Margin	14.94 %	10.14 %	24.94 %
5 yr average Debt to Equity	0.91	0.08	0.49
5yr CAGR Net Profit	n/a	-6.01 %	10.38 %
5yr Average Return on Assets	11.49 %	6.69 %	4.54 %
Shareholdings
Promoter Holding	42.99 %	41.76 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.99 %	0.0	-7.86 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Ind-Swift Lab.	Venus Remedies	Sakar Healthcare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Loan Licensing 0 Export 0 CDMO 0	Product Wise Break-Up CDMO 0 Loan Licensing 0 Pharmaceutical 0 Export 0 Others 100	Product Wise Break-Up CDMO 22.0 Loan Licensing 5.0 Pharmaceutical 0 Export 73.0
Location Wise Break-Up	Location Wise Break-Up India 27.72 International 0 Domestic 0 Others 72.28	Location Wise Break-Up India 33.0 International 0 Domestic 0 Others 67.0	Location Wise Break-Up India 0 International 55.48 Domestic 44.52
Operating Profit Break-Up	Operating Profit Break-Up India 18.87 Others 81.13	-	-
Asset Break-Up	Asset Break-Up India 67.55 Others 32.45	-	-